Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Lilly, Johnson & Johnson, Novartis and AstraZeneca have now announced manufacturing investments in the U.S., trying to ...

Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...

The biotech company Immunovant announced changes to its management team, including the naming of a new chief executive, ...

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

Physicians need to advocate for change both outside and inside their professional organizations. Here’s how to get started.